GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (XPAR:POXEL) » Definitions » Institutional Ownership

Poxel (XPAR:POXEL) Institutional Ownership : 0.02% (As of May. 30, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Poxel Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Poxel's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Poxel's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Poxel's Float Percentage Of Total Shares Outstanding is 0.00%.

Poxel Institutional Ownership Historical Data

The historical data trend for Poxel's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poxel Institutional Ownership Chart

Poxel Historical Data

The historical data trend for Poxel can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 0.07 0.07 0.16 0.09 0.02 0.02 0.02 0.02 0.02 0.02

Poxel Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Poxel (XPAR:POXEL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (XPAR:POXEL) » Definitions » Institutional Ownership
Comparable Companies
XPAR:FALG XPAR:ALHYG XPAR:ALCOX XPAR:ALTHX XPAR:ALNFL XPAR:ALPAT XPAR:ALINT XPAR:ALVET XPAR:SIGHT XPAR:ALBPS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
0RA2:UK 7PO:Germany
Address
259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007
Website
https://www.poxel.com
Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.

Poxel (XPAR:POXEL) Headlines

No Headlines